Literature DB >> 15935330

A synthesized cationic tetradecapeptide from hornet venom kills bacteria and neutralizes lipopolysaccharide in vivo and in vitro.

Guo Yibin1, Zheng Jiang, Zhou Hong, Lv Gengfa, Wang Liangxi, Wei Guo, Lu Yongling.   

Abstract

Sepsis is a complex clinical syndrome that results from a harmful host response to infection, in which foreign bacteria and lipopolysaccharide (LPS) are potent activators of different immune cells, including monocytes and macrophages. To date, there are currently few effective adjuvant therapies in clinical use except activated protein C focusing on the coagulation system. Mastoparans (MPs) are wasp venom cationic amphiphilic tetradecapeptides; these are capable of modulating various cellular activities, including stimulation of GTP-binding protein, phospholipase C and can bind to a phospholipid bilayer. Masroparan-1 (MP-1, INLKAIAALAKKLL-NH2), a tetradecapeptide toxin isolated from hornet venom, was synthesized chemically. In this study, Escherichia coli 25922 (E. coli 25922) and LPS were used to induce sepsis in an animal model. We found that MP-1 treatment at 3 mg/kg protected mice from otherwise lethal bacteria and LPS challenges. MP-1 has antibacterial capabilities against Gram-negative and Gram-positive bacteria. Its antibacterial action against E. coli may result from the destruction of bacterial membrane structures. In addition, treatment of murine peritoneal macrophages with MP-1 potently inhibited the respiratory burst. This effect maybe related to an inhibition of NADPH oxidase in the membrane. Furthermore, MP-1, bound with high-affinity to LPS and lipid A with dissociation equilibrium constants of 484 and 456 nM, respectively, and neutralized LPS in a dose-dependent manner. MP-1 also significantly reduced the expression of TLR4, TNF-alpha and IL-6 mRNA and the release of cytokines in LPS-stimulated murine peritoneal macrophages. Our results shows that the MP-1-mediated protection of mice from lethal challenge by live bacteria and LPS was associated with its bactericidal action and inhibition of inflammatory responses by macrophages to both bacteria and LPS (the release of cytokines and reactive oxygen species).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15935330     DOI: 10.1016/j.bcp.2005.04.040

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  14 in total

Review 1.  AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense.

Authors:  Yuping Lai; Richard L Gallo
Journal:  Trends Immunol       Date:  2009-02-13       Impact factor: 16.687

2.  LL-37 protects rats against lethal sepsis caused by gram-negative bacteria.

Authors:  Oscar Cirioni; Andrea Giacometti; Roberto Ghiselli; Cristina Bergnach; Fiorenza Orlando; Carmela Silvestri; Federico Mocchegiani; Alberto Licci; Barbara Skerlavaj; Marco Rocchi; Vittorio Saba; Margherita Zanetti; Giorgio Scalise
Journal:  Antimicrob Agents Chemother       Date:  2006-05       Impact factor: 5.191

3.  Leucine-rich repeat 11 of Toll-like receptor 9 can tightly bind to CpG-containing oligodeoxynucleotides, and the positively charged residues are critical for the high affinity.

Authors:  Xichun Pan; Junjie Yue; Guofu Ding; Bin Li; Xin Liu; Xinchuan Zheng; Mengchen Yu; Jun Li; Weiwei Jiang; Chong Wu; Jiang Zheng; Hong Zhou
Journal:  J Biol Chem       Date:  2012-07-20       Impact factor: 5.157

4.  Vespa tropica venom suppresses lipopolysaccharide-mediated secretion of pro-inflammatory cyto-chemokines by abrogating nuclear factor-κ B activation in microglia.

Authors:  Deepak Kumar Kaushik; Menaka Chanu Thounaojam; Arinjay Mitra; Anirban Basu
Journal:  Inflamm Res       Date:  2014-04-30       Impact factor: 4.575

5.  Ligands and Signaling of Mas-Related G Protein-Coupled Receptor-X2 in Mast Cell Activation.

Authors:  Yan-Ni Mi; Na-Na Ping; Yong-Xiao Cao
Journal:  Rev Physiol Biochem Pharmacol       Date:  2021       Impact factor: 5.545

Review 6.  What Can Pleiotropic Proteins in Innate Immunity Teach Us about Bioconjugation and Molecular Design?

Authors:  Michelle W Lee; Ernest Y Lee; Gerard C L Wong
Journal:  Bioconjug Chem       Date:  2018-06-14       Impact factor: 4.774

Review 7.  Therapeutic interventions in sepsis: current and anticipated pharmacological agents.

Authors:  Prashant Shukla; G Madhava Rao; Gitu Pandey; Shweta Sharma; Naresh Mittapelly; Ranjita Shegokar; Prabhat Ranjan Mishra
Journal:  Br J Pharmacol       Date:  2014-09-05       Impact factor: 8.739

Review 8.  Three valuable peptides from bee and wasp venoms for therapeutic and biotechnological use: melittin, apamin and mastoparan.

Authors:  Miguel Moreno; Ernest Giralt
Journal:  Toxins (Basel)       Date:  2015-04-01       Impact factor: 4.546

9.  Regulation of Toll-like receptor 4-mediated immune responses through Pasteurella multocida toxin-induced G protein signalling.

Authors:  Dagmar Hildebrand; Aline Sahr; Sabine J Wölfle; Klaus Heeg; Katharina F Kubatzky
Journal:  Cell Commun Signal       Date:  2012-08-01       Impact factor: 5.712

Review 10.  NADPH oxidase as a therapeutic target for oxalate induced injury in kidneys.

Authors:  Sunil Joshi; Ammon B Peck; Saeed R Khan
Journal:  Oxid Med Cell Longev       Date:  2013-06-06       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.